PETS
Price
$1.18
Change
-$0.01 (-0.84%)
Updated
Oct 22 closing price
Capitalization
25.58M
19 days until earnings call
Intraday BUY SELL Signals
POM
Price
$2.03
Change
-$0.98 (-32.56%)
Updated
Oct 22 closing price
Capitalization
18.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

PETS vs POM

PETS vs POM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PETS vs. POM commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PETS is a Buy and POM is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PETS with price predictions
Oct 22, 2026

PETS's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PETS turned positive on October 20, 2026. Looking at past instances where PETS's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

PETS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PETS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for PETS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.113) is normal, around the industry mean (1.309). P/E Ratio (-0.861) is within average values for comparable stocks, (-2.136). Projected Growth (PEG Ratio) (1.270) is also within normal values, averaging (0.947). PETS has a moderately high Dividend Yield (1.017) as compared to the industry average of (0.254). P/S Ratio (0.200) is also within normal values, averaging (2.504).

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. PETS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PETS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

A.I.Advisor
a Summary for POM with price predictions
Oct 22, 2026

POM's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for POM moved out of overbought territory on October 22, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 4 instances where the indicator moved out of the overbought zone. In 4 of the 4 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

POM broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for POM entered a downward trend on September 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 9 of 10 cases where POM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on POM as a result. In 17 of 19 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

The Moving Average Convergence Divergence (MACD) for POM just turned positive on October 21, 2026. Looking at past instances where POM's MACD turned positive, the stock continued to rise in 6 of 7 cases over the following month. The odds of a continued upward trend are 86%.

POM moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for POM crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +466.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where POM advanced for three days, in 53 of 60 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: POM's P/B Ratio (0.000) is slightly lower than the industry average of (1.309). P/E Ratio (0.000) is within average values for comparable stocks, (-2.136). POM's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (0.947). Dividend Yield (0.000) settles around the average of (0.254) among similar stocks. P/S Ratio (0.043) is also within normal values, averaging (2.504).

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. POM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

FUNDAMENTALS RATINGS
PETS vs POM: Fundamental Ratings
PETS
POM
OUTLOOK RATING
1..100
5295
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8834
P/E GROWTH RATING
1..100
13100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PETS's Valuation (5) in the Drugstore Chains industry is in the same range as POM (29) in the Electric Utilities industry. This means that PETS’s stock grew similarly to POM’s over the last 12 months.

PETS's Profit vs Risk Rating (100) in the Drugstore Chains industry is in the same range as POM (100) in the Electric Utilities industry. This means that PETS’s stock grew similarly to POM’s over the last 12 months.

PETS's SMR Rating (98) in the Drugstore Chains industry is in the same range as POM (100) in the Electric Utilities industry. This means that PETS’s stock grew similarly to POM’s over the last 12 months.

POM's Price Growth Rating (34) in the Electric Utilities industry is somewhat better than the same rating for PETS (88) in the Drugstore Chains industry. This means that POM’s stock grew somewhat faster than PETS’s over the last 12 months.

PETS's P/E Growth Rating (13) in the Drugstore Chains industry is significantly better than the same rating for POM (100) in the Electric Utilities industry. This means that PETS’s stock grew significantly faster than POM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PETSPOM
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 4 days ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (PETS: $1.19 vs. POM: $3.01)
Brand notoriety: PETS and POM are both not notable
Both companies represent the Drugstore Chains industry
Current volume relative to the 65-day Moving Average: PETS: 68% vs. POM: 4525%
Market capitalization -- PETS: $25.58M vs. POM: $18.81M
PETS [@Drugstore Chains] is valued at $25.58M. POM’s [@Drugstore Chains] market capitalization is $18.81M. The market cap for tickers in the [@Drugstore Chains] industry ranges from $36.55K to $14.27B. The average market capitalization across the [@Drugstore Chains] industry is $83.33M.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PETS’s FA Score shows that 2 FA rating(s) are green while POM’s FA Score has 1 green FA rating(s).

  • PETS’s FA Score: 2 green, 3 red.
  • POM’s FA Score: 1 green, 4 red.
According to our system of comparison, PETS is a better buy in the long-term than POM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PETS’s TA Score shows that 2 TA indicator(s) are bullish while POM’s TA Score has 6 bullish TA indicator(s).

  • PETS’s TA Score: 2 bullish, 2 bearish.
  • POM’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, POM is a better buy in the short-term than PETS.

Price Growth

PETS (@Drugstore Chains) experienced а -0.83% price change this week, while POM (@Drugstore Chains) price change was +368.19% for the same time period.

The average weekly price growth across all stocks in the @Drugstore Chains industry was +33.58%. For the same industry, the average monthly price growth was +10.65%, and the average quarterly price growth was -48.09%.

Reported Earning Dates

PETS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Drugstore Chains (+33.58% weekly)

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

View a ticker or compare two or three
PETS
Daily Signal:
Gain/Loss:
POM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

PETS and

Correlation & Price change

A.I.dvisor tells us that PETS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PETS and LFMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PETS
1D Price
Change %
PETS100%
-0.84%
LFMD - PETS
22%
Poorly correlated
+1.40%
HITI - PETS
20%
Poorly correlated
-1.67%
YI - PETS
19%
Poorly correlated
-2.85%
LFMDP - PETS
5%
Poorly correlated
-1.04%
HKPD - PETS
2%
Poorly correlated
-5.88%
More

POM and

Correlation & Price change

A.I.dvisor tells us that POM and SCNX have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POM and SCNX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POM
1D Price
Change %
POM100%
-32.56%
SCNX - POM
4%
Poorly correlated
-4.65%
RDGT - POM
-0%
Poorly correlated
-0.53%
HITI - POM
-2%
Poorly correlated
-1.67%
HKPD - POM
-3%
Poorly correlated
-5.88%
PETS - POM
-9%
Poorly correlated
-0.84%
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LZB30.401.72
+6.00%
La-Z-Boy
AUB40.101.42
+3.67%
Atlantic Union Bankshares Corp
PLAY7.460.23
+3.18%
Dave & Buster's Entertainment
EPD36.52-0.07
-0.19%
Enterprise Products Partners LP
RYET0.71-0.01
-1.53%
Ruanyun Edai Technology Inc.